Napatree Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$622K Sell
9,179
-762
-8% -$45.6K 0.35% 76
2024
Q4
$446K Sell
9,941
-1,556
-14% -$87.3K 0.26% 102
2024
Q3
$723K Sell
11,497
-983
-8% -$57.3K 0.5% 63
2024
Q2
$737K Sell
12,480
-2,742
-18% -$172K 0.6% 52
2024
Q1
$1.03M Sell
15,222
-462
-3% -$35.3K 1% 30
2023
Q4
$1.24M Buy
+15,684
New +$1.12M 1.24% 21

Other funds holding CVS

Napatree Capital's CVS Position: Q1 2025 in Review

Napatree Capital reduced its CVS Health (CVS) stake by 7.7% in Q1 2025, selling an estimated $45.6K and leaving 9,179 shares worth $622K. The position accounts for 0.35% of the portfolio, ranked #76.

Napatree Capital first reported a position in CVS in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.24M in Q4 2023. 1,753 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Napatree Capital held 9,179 shares of CVS Health worth $622K as of Q1 2025.
  • Napatree Capital sold 762 CVS Health shares in Q1 2025, an estimated $45.6K.
  • CVS Health made up 0.35% of Napatree Capital's portfolio in Q1 2025, its #76 holding.
  • Napatree Capital first reported a position in CVS Health in Q4 2023 and has held it in 6 quarters since.
  • Napatree Capital's CVS Health position peaked at $1.24M in Q4 2023.
  • 1,753 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.